Suchergebnisse - "Wegmann, Frank"

PubPharm (106)

41

SARS-CoV-2 binding and neutralizing antibody levels after Ad26.COV2.S vaccination predict durable protection in rhesus macaques

enthalten in: Nature communications | 2021

von Roozendaal, R. | Solforosi, L. | Stieh, D. | +23

42

Protective efficacy of Ad26.COV2.S against SARS-CoV-2 B.1.351 in macaques

enthalten in: Nature | 2021

von Yu, J. | Tostanoski, L. | Mercado, N. | +36

43

Compositions and Methods for Preventing and Treating Coronavirus Infection - SARS-COV-2 Vaccines

enthalten in: Europäisches Patentamt | 2021

von LANGEDIJK JOHANNES PETRUS MARIA | RUTTEN LUCY | BAKKERS MARK JOHANNES GERARDUS | +7

44

Compositions and Methods for Preventing and Treating Coronavirus Infection - SARS-COV-2 Vaccines

enthalten in: Europäisches Patentamt | 2021

von LANGEDIJK JOHANNES PETRUS MARIA | RUTTEN LUCY | BAKKERS MARK JOHANNES GERARDUS | +7

45

COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING CORONAVIRUS INFECTION - SARSCOV-2 VACCINES

enthalten in: Europäisches Patentamt | 2021

von LANGEDIJK JOHANNES PETRUS MARIA | RUTTEN LUCY | BAKKERS MARK | +7

46

Compositions and Vaccine Combinations Containing Synthetic Human Immunodeficiency Virus (HIV) Envelope Antigen, and Methods of Use Thereof

enthalten in: Europäisches Patentamt | 2021

von LANGEDIJK JOHANNES PETRUS MARIA | VAN MANEN DANIELLE | VELLINGA JORT | +4

47

Immunogenicity and efficacy of one and two doses of Ad26.COV2.S COVID vaccine in adult and aged NHP

enthalten in: The Journal of experimental medicine | 2021

von Solforosi, L. | Kuipers, H. | Jongeneelen, M. | +40

48

Low-dose Ad26.COV2.S protection against SARS-CoV-2 challenge in rhesus macaques

enthalten in: Cell | 2021

von He, X. | Chandrashekar, A. | Zahn, R. | +30

UpdateOf: bioRxiv. 2021 Jan 27;:. - PMID 33532782

49

Coronavirus-Specific Antibody Cross Reactivity in Rhesus Macaques Following SARS-CoV-2 Vaccination and Infection

enthalten in: Journal of virology | 2021

von Jacob-Dolan, C. | Feldman, J. | McMahan, K. | +6

50

METHOD OF INDUCING IMMUNE RESPONSE AGAINST HUMAN IMMUNODEFICIENCY VIRUS BY CO-LOCALIZED ADMINISTRATION OF VACCINE COMPONENTS

enthalten in: Europäisches Patentamt | 2021

von WEGMANN FRANK | HARDENBERG GIJS | ZAHN ROLAND CHRISTIAN